George Poste - 11 Aug 2025 Form 4 Insider Report for Caris Life Sciences, Inc.

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
13 Aug 2025, 20:07:56 UTC
Prior SEC filing
17 Jun 2025
Next SEC filing
08 May 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ J. Russel Denton, Attorney-in-Fact for George Poste

Key filing fact

George Poste filed Form 4 for Caris Life Sciences, Inc. on 13 Aug 2025.

Key facts

  • This page summarizes George Poste's Form 4 filing for Caris Life Sciences, Inc..
  • 4 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 13 Aug 2025, 20:07.

Change

  • Previous filing in this sequence was filed on 17 Jun 2025.
  • Current net transaction value: -$3,845,631.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001180770 Primary reporting owner

POSTE GEORGE

Relationship
Director
Address
C/O CARIS LIFE SCIENCES, INC., 750 W. JOHN CARPENTER FREEWAY, SUITE 800, IRVING
Signature
/s/ J. Russel Denton, Attorney-in-Fact for George Poste
Signature date
13 Aug 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CAI transaction

Common Stock

Options Exercise

Transaction value
$305,000
Shares
+125,000
Change %
+53%
Price
$2.44
Shares after
359,754
Date
11 Aug 2025
Ownership
Direct
CAI transaction

Common Stock

Tax liability

Transaction value
$1,428,654
Shares
-48,022
Change %
-13%
Price
$29.75
Shares after
311,732
Date
11 Aug 2025
Ownership
Direct
CAI transaction

Common Stock

Tax liability

Transaction value
$2,721,976
Shares
-91,495
Change %
-29%
Price
$29.75
Shares after
220,237
Date
11 Aug 2025
Ownership
Direct
CAI holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
307,594
Date
11 Aug 2025
Ownership
By Family Trust

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CAI transaction Derivative

Stock Option

Options Exercise

Transaction value
$0
Shares
+125,000
Change %
Price
$0.000000
Shares after
0
Date
11 Aug 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
125,000
Exercise price
$2.44
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The stock option is fully vested and exercisable.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .